A 8 week, Randomized, Double-blind, Placebo-Controlled Clinical Trial for the Evaluation of the Efficacy and Safety of OFE on Memory Improvement of Adolescent

Konkuk University Medical Center0 个研究点目标入组 56 人开始时间: 待定最近更新: 2023年3月6日

试验速览

暂无简介。

•1) Teenagers over 12 years of age and under 18 years of age
•2) A person who can read and read the Korean language
•3) A person who agrees to participate in this human body application test before the human body application test begins and prepares a written consent form.

•1) Person who scored 30 points as a result of MoCA-K in Visit 1
•2) Persons diagnosed with intellectual disability or ADHD
•3) A person diagnosed with a psychiatric disease that may affect cognitive function;
•4) A person who has taken neuropsychiatric medication within 4 weeks based on visit 1
•5) A person who has taken medication or health functional food related to memory improvement within 4 weeks based on visit 1.
•6) Patients with uncontrolled hypertension (systolic blood pressure of 160 mmHg or higher or diastolic blood pressure of 100 mmHg or higher, measured after 10 minutes of rest for those subject to human application tests)
•7) Patients with uncontrolled diabetes (above 180 mg/dL of fasting blood sugar)
•8) an uncontrolled thyroid patient
•9) Those with a creatine level of at least twice the normal upper limit of the implementing institution.
•10) Those whose AST (GOT) or ALT (GPT) is at least three times the normal upper limit of the agency.
•11) A person who has participated in another interventional clinical trial (including the human body application test) within 3 months of visit 1 or plans to participate in another interventional clinical trial (including the human body application test) after the start of this human body application test
•12) A person who is sensitive to or allergic to food ingredients for human application tests
•13) A person who the tester deems inappropriate for this human body application test

发起方